EDAP Announces Focal One® HIFU Reimbursement Raised

EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Proposed Rule for CY23

Read more

EDAP’s Focal One® HIFU to be Showcased at Two Major Robotics & Urology International Congresses

EDAP’s Focal One^® HIFU to be Showcased at Two Major Robotics & Urology International Congresses

Read more

EDAP holds a Symposium at 6th European Endometriosis Congress

Prof. Gil Dubernard, Head of the Gynecology Department at Croix-Rousse University Hospital, Lyon, France, will deliver a presentation at the 6th European Endometriosis Congress

Read more

EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA)

EDAP to Showcase its Focal One® Platform at the Annual Meeting of the American Urological Association (AUA)

Read more

EDAP Provides Corporate Update on US Focal One® Installation Growth

Company announces Focal One® placements at three renowned academic institutions in March

Read more

Beyond Death Valley: Medtech Veteran Breathes New Life into HIFU Company

Ryan Rhodes, new CEO of EDAP USA was featured in MDDI this week. Rhodes hales from Intuitive Surgical where he helped build the DaVinci Robot brand. He compares HIFU to the early days of robotic surgery: “The HIFU market is still in its infancy, and Rhodes said it reminds him of his early days at Intuitive Surgical, when the Irvine, CA-based robotics company was focused on prostate cancer, specifically radical prostatectomy, which was also a very young market at the time.”

Read more

EDAP's HIFU Progress Is Obscured By The Pandemic, But It's Real

Very positive article on EDAP’s future and its advances on #HIFU, written by Seeking Alpha. Read more

EDAP Announces Hiring of MedTech Industry Veteran Ryan Rhodes as CEO of Company’s U.S. Subsidiary

LYON, France, June 15, 2021 -- EDAP TMS SA, the global leader in robotic energy-based therapies, announced today that the company has hired medical technology industry veteran Ryan Rhodes as Chief Executive Officer of EDAP Technomed, the Company’s U.S. subsidiary. Read more

In the C-Suite with Marc Oczachowski, CEO, EDAP TMS

We venture to Lyon, France to learn how Marc and his team fresh off a $28 million raise are setting the stage to dominate High Intensity Focused Ultrasound (HIFU) for prostate cancer. Read more

EDAP Selects Leading Reimbursement Consultancies MTP and Argenta Advisors to Expand Market Access and Coverage of HIFU in the US

EDAP TMS, the global leader in robotic energy-based therapies, announces today that the company has selected Medical Technology Partners (MTP) and Argenta Advisors, two leading reimbursement consultancies, to further expand coverage, accelerate market access and secure future payment rates for the company’s Focal One high intensity focused ultrasound (HIFU) procedure in the US. The announcement follows the establishment of a Category 1 CPT code, and physician reimbursement for HIFU, that went into effect on January 1, 2021. Read more